ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bisgaard, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bisgaard, H
Eur Respir J 1995; 8: 856-860
Copyright © ERS Journals Ltd 1995

Clinical Trial

A metal aerosol holding chamber devised for young children with asthma

H Bisgaard

The low tidal volume and flow in preschool children may reduce the efficiency of aerosol delivery from a pressurized metered-dose inhaler (pMDI) through a traditional holding chamber. A prototype small-volume steel holding chamber with two one-way valves was devised to prolong aerosol availability in the chamber and to ensure unidirectional airflow. Dead space between the valves was minimized to less than 2 ml. The dose-delivery and rate of passive disappearance of a budesonide pMDI aerosol were compared between this prototype and the large-volume, single-valved plastic Nebuhaler, in 164 asthmatic children less than 8 yrs of age. In vitro, the half life of aerosol disappearance in the steel prototype and the plastic Nebuhaler was > 30 s and 9 s, respectively. In vivo, the prototype delivered an age-independent mean dose of 38% of the nominal dose, and the Nebuhaler delivered an age-dependent mean dose, ranging from 42% of the nominal dose in children > or = 4 yrs to 19% of the nominal dose in infants. We conclude that the use of plastic for holding chambers may influence dose-delivery, and single-valve control may cause age-dependent dose-delivery. Reproducible age-independent drug-delivery may be achieved by pMDI aerosol inhaled through a small-volume metal holding chamber with separate inlet and outlet valves and minimized dead space. This holding chamber would improve the possibilities of aerosol therapy for young children.


This article has been cited by other articles:


Home page
 NEJMHome page
D. Kohler, P. Haidl, D. Dellweg, L. Bont, J. L.L. Kimpen, M. J.J. Ermers, E. Baraldi, M. Filippone, T. Guilbert, F. D. Martinez, et al.
Inhaled corticosteroids and children.
N. Engl. J. Med., August 10, 2006; 355(6): 624 - 624.
[Full Text] [PDF]

Home page
 ChestHome page
J. Esposito-Festen, H. Ijsselstijn, W. Hop, F. van Vliet, J. de Jongste, and H. Tiddens
Aerosol Therapy by Pressured Metered-Dose Inhaler-Spacer in Sleeping Young Children: To Do or Not to Do?
Chest, August 1, 2006; 130(2): 487 - 492.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
Inhalation devices
Can. Med. Assoc. J., September 13, 2005; 173(6_suppl): S39 - S45.
[Full Text] [PDF]

Home page
 JAMAHome page
H. A. Cohen, Z. Cohen, and E. Kahan
Bacterial Contamination of Spacer Devices Used by Children With Asthma
JAMA, July 9, 2003; 290(2): 195 - 196.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
I Amirav, Y Mansour, T Tiosano, S Chamny, S Chirurg, S Oren, Z Grossman, L Kahana, E Kahan, and M T Newhouse
Safety of inhaled corticosteroids delivered by plastic and metal spacers
Arch. Dis. Child., June 1, 2003; 88(6): 527 - 528.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
I. Amirav and M. T. Newhouse
Aerosol Therapy With Valved Holding Chambers in Young Children: Importance of the Facemask Seal
Pediatrics, August 1, 2001; 108(2): 389 - 394.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. BUCHVALD and H. BISGAARD
FeNO Measured at Fixed Exhalation Flow Rate during Controlled Tidal Breathing in Children from the Age of 2 Yr
Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 699 - 704.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
E Dompeling, A M Oudesluys-Murphy, H M Janssens, W Hop, J G Brinkman, R N Sukhai, and J C de Jongste
Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge
Arch. Dis. Child., February 1, 2001; 84(2): 178 - 182.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. A. ØJ, L. THORSSON, and H. BISGAARD
Lung Deposition of Inhaled Drugs Increases with Age
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1819 - 1822.
[Abstract] [Full Text]

Home page
 ChestHome page
A. Mandelberg, S. Tsehori, S. Houri, E. Gilad, B. Morag, and I. E. Priel
Is Nebulized Aerosol Treatment Necessary in the Pediatric Emergency Department?
Chest, May 1, 2000; 117(5): 1309 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
C. O'Callaghan and P. W Barry
Asthma drug delivery devices for children
BMJ, March 11, 2000; 320(7236): 664 - 664.
[Full Text]

Home page
 Arch. Dis. Child.Home page
C. O'CALLAGHAN and P. W BARRY
How to choose delivery devices for asthma
Arch. Dis. Child., March 1, 2000; 82(3): 185 - 187.
[Full Text]

Home page
 CMAJHome page
Inhalation devices and propellants
Can. Med. Assoc. J., November 1, 1999; 161(90111): s44 - 50.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. BISGAARD
Automatic Actuation of a Dry Powder Inhaler into a Nonelectrostatic Spacer
Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 518 - 521.
[Abstract] [Full Text]

Home page
 BMJHome page
H. Bisgaard
Drug delivery from inhaler devices
BMJ, October 12, 1996; 313(7062): 895 - 896.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.